Errol Taylor is a partner in the New York office of Milbank, Tweed, Hadley & McCloy and leads the firm’s biopharma patent litigation practice. A partner since 2003, Mr. Taylor chairs Milbank’s Diversity Committee.
Primary Focus & Experience
Mr. Taylor focuses mainly on representing research pharmaceutical and biotechnology companies in patent litigation and related counseling. He has particular expertise in cases involving generic drug approvals and the Hatch-Waxman Act. Mr. Taylor has served as lead trial counsel in numerous multi-party, multinational cases involving some of the world’s most prescribed medicines.
Mr. Taylor has given lectures in the areas of pharmaceutical litigation, interference procedure, damages and injunctions to various legal professional associations, including The American Bar Association; American Intellectual Property Law Association; Federal Circuit Bar Association; Pharmaceutical Research Manufacturers Association; National Bar Association; New York Intellectual Property Law Association; and The Association of the Bar for the City of New York.
His litigations include:
- lead counsel in seven-month multiparty trial and appeals involving the world’s largest selling drug
- lead counsel for biotechnology company in litigation involving human papillomavirus tests
- lead counsel in litigation involving formulations for administration of antidepressant
- lead counsel in trial and appeals regarding treatment for impaired glucose tolerance and diabetes
- counsel for chemical company in litigation regarding polyester fiber technology
-
counsel for biotechnology company in ITC litigation regarding cancer treatment
Recognition & Accomplishments
Mr. Taylor has been recognized as one of the world’s leading pharmaceutical litigators by numerous publications and journals, among them: Chambers USA, PLC Which Lawyers?, Super Lawyers, and IAM Magazine, which selected him as one of the 250 top patent litigators in the world and in the first tier of New York lawyers. In 2003, he was selected by The National Law Journal as one of the nation's top trial lawyers.
Mr. Taylor received an honorary PhD degree from the State University of New York at Oswego in 2006, is President of the Board of Trustees of the Chapin School in Princeton, NJ, and serves on the board of The Young Scholar’s Institute in Trenton, NJ.